Publisher
Springer Science and Business Media LLC
Subject
Genetics(clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine
Reference25 articles.
1. Maron, B. J., Spirito, P., Shen, W. K., et al. (2007). Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA, 298, 405–412.
2. Maron, B. J., Spirito, P., Ackerman, M. J., et al. (2013). Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. Journal of the American College of Cardiology, 61, 1527–1535.
3. Moon, J. C., McKenna, W. J., McCrohon, J. A., Elliott, P. M., Smith, G. C., & Pennell, D. J. (2003). Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. Journal of the American College of Cardiology, 41, 1561–1567.
4. Adabag, A. S., Maron, B. J., Appelbaum, E., et al. (2008). Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. Journal of the American College of Cardiology, 51, 1369–1374.
5. Weng, Z., Yao, J., Chan, R. H., et al. (2016). Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC: Cardiovascular Imaging, 9(12), 1392–1402.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献